• head_banner_01

Unreinheden fan aminosoer brûkt foar synthesize protein

Koarte beskriuwing:

NO

Products

CAS nr

1

Fmoc-D-Ala-D-Ala-OH

NA

2

Fmoc-β-Ala-D-Ala-OH

NA

3

Fmoc-Arg(pbf)-Arg(pbf)-OH

NA


Produkt Detail

Produkt Tags

Produkt Detail

NO

Products

CAS nr

Key Quality Indicator

Purity

Max.

ûnreinheit

Totale oplosmiddel residu

Moisture

1

Fmoc-β-Ala-Ala-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

2

Fmoc-D-Ala-D-Ala-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

3

Fmoc-β-Ala-D-Ala-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

4

Fmoc-Arg(pbf)-Arg(pbf)-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

5

Fmoc-β-Ala-Arg(pbf)-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

6

Fmoc-D-Arg(pbf)-D-Arg(pbf)-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

7

Fmoc-β-Ala-D-Arg(pbf)-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

8

Fmoc-HomoArg(pbf)-HomoArg(pbf)-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

9

Fmoc-β-Ala-HomoArg(pbf)-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

10

Fmoc-Asn(Trt)-Asn(Trt)-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

11

Fmoc-β-Ala-Asn(Trt)-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

12

Fmoc-Asp(OtBu)-Asp(OtBu)-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

13

Fmoc-β-Ala-Asp(OtBu)-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

14

Fmoc-Cys(Trt)-Cys(Trt)-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

15

Fmoc-β-Ala-Cys(Trt)-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

16

Fmoc-Cys(Acm)-Cys(Acm)-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

17

Fmoc-β-Ala-Cys(Acm)-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

18

Fmoc-Gln(Trt)-Gln(Trt)-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

19

Fmoc-β-Ala-Gln(Trt)-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

20

Fmoc-Glu(OtBu)-Glu(OtBu)-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

21

Fmoc-β-Ala-Glu(OtBu)-OH.H2O

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

22

Fmoc-β-Ala-Gly-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

23

Fmoc-His(Trt)-His(Trt)-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

24

Fmoc-β-Ala-His(Trt)-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

25

Fmoc-Ile-Ile-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

26

Fmoc-β-Ala-Ile-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

27

Fmoc-Leu-Leu-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

28

Fmoc-β-Ala-Leu-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

29

Fmoc-D-Leu-D-Leu-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

30

Fmoc-β-Ala-D-Leu-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

31

Fmoc-Lys(Boc)-Lys(Boc)-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

32

Fmoc-β-Ala-Lys(Boc)-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

33

Fmoc-Lys(Alloc)-Lys(Alloc)-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

34

Fmoc-β-Ala-Lys(Alloc)-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

35

Fmoc-Met-Met-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

36

Fmoc-β-Ala-Met-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

37

Fmoc-Orn(Boc)-Orn(Boc)-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

38

Fmoc-β-Ala-Orn(Boc)-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

39

Fmoc-Phe-Phe-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

40

Fmoc-β-Ala-Phe-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

41

Fmoc-D-Phe-D-Phe-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

42

Fmoc-β-Ala-D-Phe-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

43

Fmoc-Pro-Pro-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

44

Fmoc-β-Ala-Pro-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

45

Fmoc-Ser(tBu)-Ser(tBu)-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

46

Fmoc-β-Ala-Ser(tBu)-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

47

Fmoc-Ser(Trt)-Ser(Trt)-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

48

Fmoc-β-Ala-Ser(Trt)-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

49

Fmoc-Thr(tBu)-Thr(tBu)-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

50

Fmoc-β-Ala-Thr(tBu)-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

51

Fmoc-Trp(Boc)-Trp(Boc)-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

52

Fmoc-β-Ala-Trp(Boc)-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

53

Fmoc-D-Trp(Boc)-D-Trp(Boc)-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

54

Fmoc-β-Ala-D-Trp(Boc)-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

55

Fmoc-Tyr(tBu)-Tyr(tBu)-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

56

Fmoc-β-Ala-Tyr(tBu)-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

57

Fmoc-D-Tyr(Et)-D-Tyr(Et)-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

58

Fmoc-β-Ala-D-Tyr(Et)-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

59

Fmoc-Tyr(Me)-Tyr(Me)-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

60

Fmoc-β-Ala-Tyr(Me)-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

61

Fmoc-Val-Val-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

62

Fmoc-β-Ala-Val-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

63

Fmoc-D-Cit-D-Cit-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

64

Fmoc-β-Ala-D-Cit-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

65

Fmoc-β-Ala-Dab-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

66

Fmoc-(3-(2-naftyl)-D-Ala)2-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

67

Fmoc-β-Ala-3-(2-naftyl)-D-Ala-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

68

Fmoc-(3-(3-pyridinyl)-D-Ala)2-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

69

Fmoc-β-Ala-3-(3-pyridinyl)-D-Ala-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

70

Fmoc-(4-chloro-D-Phe)2-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

71

Fmoc-β-Ala-4-chloro-D-Phe-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

72

Fmoc-(D-4Aph(tBuCbm))2-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

73

Fmoc-β-Ala-D-4Aph(tBuCbm)-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

74

Fmoc-Aph(L-Hor)-Aph(L-Hor)-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

75

Fmoc-β-Ala-Aph(L-Hor)-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

76

Fmoc-Lys(iPr,Boc)-Lys(iPr,Boc)-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

77

Fmoc-β-Ala-Lys(iPr,Boc)-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

78

Fmoc-β-Ala-AEEA-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

79

Fmoc-Aib-Aib-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

80

Fmoc-β-Ala-Aib-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

81

Fmoc-Arg-OH

91000-69-0

≥98.0%

≤1,0%

≤8.0%

≤2,0%

82

H-Arg(pbf)-OH

200115-86-2

≥98.0%

≤1,0%

≤8.0%

≤2,0%

83

Fmoc-D-Arg-OH

130752-32-8

≥98.0%

≤1,0%

≤8.0%

≤2,0%

84

HD-Arg(pbf)-OH

200116-81-0

≥98.0%

≤1,0%

≤8.0%

≤2,0%

85

Fmoc-HomoArg-OH.HCl

208174-14-5

≥98.0%

≤1,0%

≤8.0%

≤2,0%

86

H-HomoArg(pbf)-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

87

Fmoc-D-HomoArg-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

88

HD-HomoArg(pbf)-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

89

Fmoc-Asn-OH

71989-16-7

≥98.0%

≤1,0%

≤8.0%

≤2,0%

90

H-Asn(Trt)-OH

132388-58-0

≥98.0%

≤1,0%

≤8.0%

≤2,0%

91

Fmoc-Asp-OH

119062-05-4

≥98.0%

≤1,0%

≤8.0%

≤2,0%

92

H-Asp(OtBu)-OH

3057-74-7

≥98.0%

≤1,0%

≤8.0%

≤2,0%

93

Fmoc-Cys-OH

135248-89-4

≥98.0%

≤1,0%

≤8.0%

≤2,0%

94

H-Cys(Trt)-OH

2799/7/7

≥98.0%

≤1,0%

≤8.0%

≤2,0%

95

H-Cys(Acm)-OH.HCl

28798-28-9

≥98.0%

≤1,0%

≤8.0%

≤2,0%

96

Fmoc-Gln-OH

71989-20-3

≥98.0%

≤1,0%

≤8.0%

≤2,0%

97

H-Gln(Trt)-OH

102747-84-2

≥98.0%

≤1,0%

≤8.0%

≤2,0%

98

Fmoc-Glu-OH

121343-82-6

≥98.0%

≤1,0%

≤8.0%

≤2,0%

99

H-Glu(OtBu)-OH.H2O

2419-56-9

≥98.0%

≤1,0%

≤8.0%

≤2,0%

100

Fmoc-His-OH

116611-64-4

≥98.0%

≤1,0%

≤8.0%

≤2,0%

101

H-His(Trt)-OH

35146-32-8

≥98.0%

≤1,0%

≤8.0%

≤2,0%

102

Boc-His-OH

17791-52-5

≥98.0%

≤1,0%

≤8.0%

≤2,0%

103

Fmoc-Lys-OH

105047-45-8

≥98.0%

≤1,0%

≤8.0%

≤2,0%

104

H-Lys(Boc)-OH

2418-95-3

≥98.0%

≤1,0%

≤8.0%

≤2,0%

105

H-Lys(Alloc)-OH

6298/3/9

≥98.0%

≤1,0%

≤8.0%

≤2,0%

106

Fmoc-Orn-OH.HCl

201046-57-3

≥98.0%

≤1,0%

≤8.0%

≤2,0%

107

H-Orn(Boc)-OH

13650-49-2

≥98.0%

≤1,0%

≤8.0%

≤2,0%

108

Fmoc-Ser-OH

73724-45-5

≥98.0%

≤1,0%

≤8.0%

≤2,0%

109

H-Ser(tBu)-OH

18822-58-7

≥98.0%

≤1,0%

≤8.0%

≤2,0%

110

H-Ser(Trt)-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

111

Fmoc-Thr-OH.H2O

73731-37-0

≥98.0%

≤1,0%

≤8.0%

≤2,0%

112

H-Thr(tBu)-OH

4378-13-6

≥98.0%

≤1,0%

≤8.0%

≤2,0%

113

Fmoc-Trp-OH

35737-15-6

≥98.0%

≤1,0%

≤8.0%

≤2,0%

114

H-Trp(Boc)-OH

146645-63-8

≥98.0%

≤1,0%

≤8.0%

≤2,0%

115

Fmoc-D-Trp-OH

86123-11-7

≥98.0%

≤1,0%

≤8.0%

≤2,0%

116

HD-Trp(Boc)-OH

201290-11-1

≥98.0%

≤1,0%

≤8.0%

≤2,0%

117

Fmoc-Tyr-OH

92954-90-0

≥98.0%

≤1,0%

≤8.0%

≤2,0%

118

H-Tyr(tBu)-OH

18822-59-8

≥98.0%

≤1,0%

≤8.0%

≤2,0%

119

Fmoc-D-Tyr-OH

112883-29-1

≥98.0%

≤1,0%

≤8.0%

≤2,0%

120

HD-Tyr(Et)-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

121

H-Tyr(Me)-OH.HCl

67423-44-3

≥98.0%

≤1,0%

≤8.0%

≤2,0%

122

Fmoc-D-4Aph(Cbm)-OH

324017-22-3

≥98.0%

≤1,0%

≤8.0%

≤2,0%

123

HD-4Aph(tBuCbm)-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

124

Fmoc-Lys(iPr)-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

125

H-Lys(iPr,Boc)-OH

NA

≥98.0%

≤1,0%

≤8.0%

≤2,0%

Oer

Kompensaasje

Gentolex leverje produkten fan geweldige kwaliteit, as ienige produktkwaliteit wurdt ferhege troch de klant binnen it fereaske tiidframe mei genôch bewiis, sille wy de nedige analyze en evaluaasje leverje om de prosedueres fan kompensaasje te triggerjen.

Produksje

De kapasiteiten fan farmaseutyske produkten berikten tonklasse, de kapasiteiten fan gemyske produkten berikke 100tons+ klasse, de mooglikheden binne goed útrist om kliïnten wrâldwiid te tsjinjen.

Ûndersyk en ûntwikkeling

Elk jier is d'r plan opsteld troch it R&D-team om ferskate nije produkten te ûntwikkeljen, as doelen steld wurde, sil elk lid yn it team moatte trochgean mei KPI-ferantwurdlikens en mei stimulearringsbelied.


  • Foarige:
  • Folgjende:

  • Skriuw jo berjocht hjir en stjoer it nei ús